Consonance Capital Management’s NEVRO CORP. NVRO Stock Holding History

Consonance Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,446,333	Closed	-$82.4M	–	29
2018 Q3	$82.4M	Buy	1,446,333 +503,263	+53%	+$31.5M	4.44%	7
2018 Q2	$75.3M	Buy	+943,070	New	+$78.2M	4.86%	7

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Consonance Capital Management's NVRO Position: Q4 2018 in Review

Consonance Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 1,446,333 shares — an estimated $82.4M sold.

Consonance Capital Management first reported a position in NVRO in Q2 2018 and held it in 2 quarters. The position peaked at $82.4M in Q3 2018. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

Consonance Capital Management reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
Consonance Capital Management sold 1,446,333 NEVRO CORP. shares in Q4 2018, an estimated $82.4M.
Consonance Capital Management first reported a position in NEVRO CORP. in Q2 2018 and held it in 2 quarters.
Consonance Capital Management's NEVRO CORP. position peaked at $82.4M in Q3 2018.
157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Consonance Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.